CLBT - Cellebrite DI - Stock Price & Dividends

Exchange: USA Stocks • Country: Israel • Currency: USD • Type: Common Stock • ISIN: IL0011794802

Digital Forensics, Data Analysis, Case Management, Training Services

Cellebrite DI Ltd. is a leading provider of digital intelligence solutions, serving law enforcement agencies, enterprises, and service providers across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

The company's flagship DI suite of solutions empowers users to efficiently collect, review, analyze, and manage digital data throughout the investigative lifecycle, supporting legally sanctioned investigations in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.

Cellebrite's digital forensics software, Inseyts, enables the collection and review of digital evidence from diverse digital sources, including computers, mobile devices, and cloud storage. The software offers advanced features such as data extraction, decoding capabilities, workflows, and automation capabilities, streamlining the digital evidence collection process.

In addition to Inseyts, the company offers a range of innovative solutions, including Cellebrite Pathfinder, which automates data analysis and visualization, significantly reducing the time spent manually reviewing digital evidence. Smart Search, an open-source intelligence tool, automates the collection and review of publicly available online data, while Guardian provides a comprehensive case and evidence management solution.

Cellebrite also provides digital forensic software tailored to the needs of enterprises and service providers, including Inseyts for Enterprise, Endpoint Inspector, and Mobile Now. Furthermore, the company offers professional services, such as training and certification services, to support its customers in maximizing the potential of its solutions.

The company's solutions are designed to support federal, state, and local agencies in their efforts to combat crime and protect public safety. Headquartered in Petah Tikva, Israel, Cellebrite DI Ltd. is a trusted partner for law enforcement agencies and organizations worldwide. For more information, visit https://www.cellebrite.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for CLBT - Cellebrite DI  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for CLBT - Cellebrite DI  - Stock Price & Dividends

CLBT Stock Overview

Market Cap in USD 3,747m
Sector Technology
Industry Software - Infrastructure
GiC SubIndustry Application Software
TER 0.00%
IPO / Inception 2021-08-31

CLBT Stock Ratings

Growth 5y 46.2
Fundamental 52.4
Dividend 0.00
Rel. Performance vs Sector 6.33
Analysts 4.75/5
Fair Price Momentum 21.90 USD
Fair Price DCF 6.21 USD

CLBT Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

CLBT Growth Ratios

Growth 12m 158.60%
Growth Correlation 12m 93.5%
Growth Correlation 3m 84%
CAGR 5y 17.85%
CAGR/Mean DD 5y 0.58
Sharpe Ratio 12m 4.09
Alpha vs SP500 12m 112.68
Beta vs SP500 5y weekly 1.22
ValueRay RSI 78.57
Volatility GJR Garch 1y 37.06%
Price / SMA 50 10.39%
Price / SMA 200 48.04%
Current Volume 1075.9k
Average Volume 20d 1158.8k

External Links for CLBT Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of CLBT stocks?
As of October 18, 2024, the stock is trading at USD 18.49 with a total of 1,075,918 shares traded.
Over the past week, the price has changed by +4.23%, over one month by +5.90%, over three months by +44.57% and over the past year by +166.04%.
What are the forecast for CLBT stock price target?
According to ValueRays Forecast Model, CLBT Cellebrite DI will be worth about 24.5 in October 2025. The stock is currently trading at 18.49. This means that the stock has a potential upside of +32.34%.
Issuer Forecast Upside
Wallstreet Target Price 18.2 -1.73
Analysts Target Price 9.8 -47.0
ValueRay Target Price 24.5 32.3